Evidence map›Paper›PMID 24140559›Full record

ArticleInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2013

Vertical transmission of hepatitis C virus: a tale of multiple outcomes.

Alejandro Escobar-Gutiérrez, Hugo Soudeyns, Ariane Larouche, Juan Carlos Carpio-Pedroza, Armando Martinez-Guarneros, Carlos A Vazquez-Chacon, Salvador Fonseca-Coronado, Lilian H T Yamasaki, Karina Ruiz-Tovar, Mayra Cruz-Rivera

Open access · greenAbstract read
In one paragraph

Article in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Alejandro Escobar-GutiérrezInstituto de Diagnóstico y Referencia Epidemiológicos, Mexico City, Mexico.
Hugo Soudeyns
Ariane Larouche
Juan Carlos Carpio-Pedroza
Armando Martinez-Guarneros
Carlos A Vazquez-Chacon
Salvador Fonseca-Coronado
Lilian H T Yamasaki
Karina Ruiz-Tovar
Mayra Cruz-Rivera
Secretaria de Salud · MXUniversidad Nacional Autónoma de México · MXUniversité de Montréal · CAUniversidade Estadual Paulista (Unesp) · BR

Funding

CIHR 131561-1CIHR 41537-1CIHR 98831-1CIHR EOP-41537
6 · The paper itself

Abstract

Globally, hepatitis C virus (HCV) infection affects approximately 130 million people and 3 million new infections occur annually. HCV is also recognized as an important cause of chronic liver disease in children. The absence of proofreading properties of the HCV RNA polymerase leads to a highly error prone replication process, allowing HCV to escape host immune response. The adaptive nature of HCV evolution dictates the outcome of the disease in many ways. Here, we investigated the molecular evolution of HCV in three unrelated children who acquired chronic HCV infection as a result of mother-to-child transmission, two of whom were also coinfected with HIV-1. The persistence of discrete HCV variants and their population structure were assessed using median joining network and Bayesian approaches. While patterns of viral evolution clearly differed between subjects, immune system dysfunction related to HIV coinfection or persistent HCV seronegativity stand as potential mechanisms to explain the lack of molecular evolution observed in these three cases. In contrast, treatment of HCV infection with PegIFN, which did not lead to sustained virologic responses in all 3 cases, was not associated with commensurate variations in the complexity of the variant spectrum. Finally, the differences in the degree of divergence suggest that the mode of transmission of the virus was not the main factor driving viral evolution.

Indexed as

Infectious Disease Transmission, VerticalAntiviral AgentsChildCoinfectionEvolution, MolecularFemaleGenetic VariationHepacivirusHepatitis C, ChronicHIV-1HIV InfectionsHIV SeropositivityHumansInterferon-alphaInterferon alpha-2MaleAntiviral AgentsInterferon-alphaInterferon alpha-2peginterferon alfa-2bPolyethylene GlycolsRecombinant ProteinsRibavirinRNA, ViralHepatitis C virusMolecular evolutionVertical transmission

Identifiers

PMID24140559
PMCPMC5042690
OpenAlexW1985441392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.